[email protected] +357 96 030922 Contact Us | FAQ |
Advanced search

Pharmaceuticals Market Research Reports & Industry Analysis

Publications found: 36,694
Sort by:

Intermediate Conductance Calcium Activated Potassium Channel Protein 4 (KCa3.1 or Gardos Channel or KCNN4) - Drugs in Development, 2021

 US$ 3,000.00

Intermediate Conductance Calcium Activated Potassium Channel Protein 4 (KCa3.1 or Gardos Channel or KCNN4) - Drugs in Development, 2021 SUMMARY Intermediate Conductance Calcium Activated Potassium Cha...

April 2021 35 pages

Intermediate Uveitis (Ophthalmology) - Drugs in Development, 2021

 US$ 2,000.00

Intermediate Uveitis (Ophthalmology) - Drugs in Development, 2021 SUMMARY Intermediate Uveitis (Ophthalmology) - Drugs in Development, 2021 provides an overview of the Intermediate Uveitis pipeline la...

April 2021 35 pages

Interstitial Cystitis (Painful Bladder Syndrome/Bladder Pain Syndrome) (Genito Urinary System And Sex Hormones) - Drugs in Development, 2021

 US$ 2,000.00

Interstitial Cystitis (Painful Bladder Syndrome/Bladder Pain Syndrome) (Genito Urinary System And Sex Hormones) - Drugs in Development, 2021 SUMMARY Interstitial Cystitis (Painful Bladder Syndrome/Bla...

April 2021 45 pages

Interstitial Lung Diseases (Diffuse Parenchymal Lung Disease) (Respiratory) - Drugs in Development, 2021

 US$ 2,000.00

Interstitial Lung Diseases (Diffuse Parenchymal Lung Disease) (Respiratory) - Drugs in Development, 2021 SUMMARY Interstitial Lung Diseases (Diffuse Parenchymal Lung Disease) (Respiratory) - Drugs in...

April 2021 45 pages

Interstitial Lung Fibrosis (Respiratory) - Drugs in Development, 2021

 US$ 2,000.00

Interstitial Lung Fibrosis (Respiratory) - Drugs in Development, 2021 SUMMARY Interstitial Lung Fibrosis (Respiratory) - Drugs in Development, 2021 provides an overview of the Interstitial Lung Fibros...

April 2021 30 pages

Intracerebral Hemorrhage (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Intracerebral Hemorrhage (Central Nervous System) - Drugs in Development, 2021 SUMMARY Intracerebral Hemorrhage (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Intrac...

April 2021 50 pages

Ischemia (Cardiovascular) - Drugs in Development, 2021

 US$ 2,000.00

Ischemia (Cardiovascular) - Drugs in Development, 2021 SUMMARY Ischemia (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Ischemia pipeline landscape. The report provides compr...

April 2021 65 pages

Ischemic Cardiomyopathy (Cardiovascular) - Drugs in Development, 2021

 US$ 2,000.00

Ischemic Cardiomyopathy (Cardiovascular) - Drugs in Development, 2021 SUMMARY Ischemic Cardiomyopathy (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Ischemic Cardiomyopathy...

April 2021 35 pages

Ischemic Stroke (Central Nervous System) - Drugs in Development, 2021

 US$ 2,500.00

Ischemic Stroke (Central Nervous System) - Drugs in Development, 2021 SUMMARY Ischemic Stroke (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Ischemic Stroke pipeline...

April 2021 190 pages

Isocitrate Dehydrogenase [NADP] Mitochondrial (NADP(+)-Specific ICDH or Oxalosuccinate Decarboxylase or ICD M or IDP or IDH2 or EC 1.1.1.42) - Drugs in Development, 2021

 US$ 3,000.00

Isocitrate Dehydrogenase [NADP] Mitochondrial (NADP(+)-Specific ICDH or Oxalosuccinate Decarboxylase or ICD M or IDP or IDH2 or EC 1.1.1.42) - Drugs in Development, 2021 SUMMARY Isocitrate Dehydrogena...

April 2021 35 pages

Janus Kinase (JAK or EC 2.7.10.2) - Drugs in Development, 2021

 US$ 3,000.00

Janus Kinase (JAK or EC 2.7.10.2) - Drugs in Development, 2021 SUMMARY Janus Kinase (JAK or EC 2.7.10.2) - Drugs in Development, 2021 provides in depth analysis on Janus Kinase (JAK or EC 2.7.10.2) ta...

April 2021 50 pages

Juvenile Rheumatoid Arthritis (Immunology) - Drugs in Development, 2021

 US$ 2,000.00

Juvenile Rheumatoid Arthritis (Immunology) - Drugs in Development, 2021 SUMMARY Juvenile Rheumatoid Arthritis (Immunology) - Drugs in Development, 2021 provides an overview of the Juvenile Rheumatoid...

April 2021 30 pages

Kappa Type Opioid Receptor (KOR1 or OPRK or OPRK1) - Drugs in Development, 2021

 US$ 3,000.00

Kappa Type Opioid Receptor (KOR1 or OPRK or OPRK1) - Drugs in Development, 2021 SUMMARY Kappa Type Opioid Receptor (KOR1 or OPRK or OPRK1) - Drugs in Development, 2021 provides in depth analysis on Ka...

April 2021 170 pages

Kelch Like ECH Associated Protein 1 (Cytosolic Inhibitor Of Nrf2 or Inrf2 or Kelch Like Protein 19 or KEAP1) - Drugs in Development, 2021

 US$ 3,000.00

Kelch Like ECH Associated Protein 1 (Cytosolic Inhibitor Of Nrf2 or Inrf2 or Kelch Like Protein 19 or KEAP1) - Drugs in Development, 2021 SUMMARY Kelch Like ECH Associated Protein 1 (Cytosolic Inhibit...

April 2021 30 pages

Kennedy’s Disease (Spinal and Bulbar Muscular Atrophy) (Genetic Disorders) - Drugs in Development, 2021

 US$ 2,000.00

Kennedy’s Disease (Spinal and Bulbar Muscular Atrophy) (Genetic Disorders) - Drugs in Development, 2021 SUMMARY Kennedy’s Disease (Spinal and Bulbar Muscular Atrophy) (Genetic Disorders) - Drugs in De...

April 2021 30 pages

Keratoconjunctivitis (Ophthalmology) - Drugs in Development, 2021

 US$ 2,000.00

Keratoconjunctivitis (Ophthalmology) - Drugs in Development, 2021 SUMMARY Keratoconjunctivitis (Ophthalmology) - Drugs in Development, 2021 provides an overview of the Keratoconjunctivitis pipeline la...

April 2021 30 pages

Ketohexokinase (Hepatic Fructokinase or KHK or EC 2.7.1.3) - Drugs in Development, 2021

 US$ 3,000.00

Ketohexokinase (Hepatic Fructokinase or KHK or EC 2.7.1.3) - Drugs in Development, 2021 SUMMARY Ketohexokinase (Hepatic Fructokinase or KHK or EC 2.7.1.3) - Drugs in Development, 2021 provides in dept...

April 2021 30 pages

Kidney Disease (Nephropathy) (Genito Urinary System And Sex Hormones) - Drugs in Development, 2021

 US$ 2,000.00

Kidney Disease (Nephropathy) (Genito Urinary System And Sex Hormones) - Drugs in Development, 2021 SUMMARY Kidney Disease (Nephropathy) (Genito Urinary System And Sex Hormones) - Drugs in Development,...

April 2021 115 pages

Klebsiella Infections (Infectious Disease) - Drugs in Development, 2021

 US$ 2,000.00

Klebsiella Infections (Infectious Disease) - Drugs in Development, 2021 SUMMARY Klebsiella Infections (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Klebsiella Infection...

April 2021 30 pages

Knee Osteoarthritis (Musculoskeletal Disorders) - Drugs in Development, 2021

 US$ 2,000.00

Knee Osteoarthritis (Musculoskeletal Disorders) - Drugs in Development, 2021 SUMMARY Knee Osteoarthritis (Musculoskeletal Disorders) - Drugs in Development, 2021 provides an overview of the Knee Osteo...

April 2021 100 pages

Kynurenine 3 Monooxygenase (Kynurenine 3 Hydroxylase or KMO or EC 1.14.13.9) - Drugs in Development, 2021

 US$ 3,000.00

Kynurenine 3 Monooxygenase (Kynurenine 3 Hydroxylase or KMO or EC 1.14.13.9) - Drugs in Development, 2021 SUMMARY Kynurenine 3 Monooxygenase (Kynurenine 3 Hydroxylase or KMO or EC 1.14.13.9) - Drugs i...

April 2021 30 pages

Lafora Disease (Unverricht Disease) (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Lafora Disease (Unverricht Disease) (Central Nervous System) - Drugs in Development, 2021 SUMMARY Lafora Disease (Unverricht Disease) (Central Nervous System) - Drugs in Development, 2021 provides an...

April 2021 30 pages

Laminin-Deficient Congenital Muscular Dystrophy (LAMA2 MD or LAMA2-Related Muscular Dystrophy) (Musculoskeletal Disorders) - Drugs in Development, 2021

 US$ 2,000.00

Laminin-Deficient Congenital Muscular Dystrophy (LAMA2 MD or LAMA2-Related Muscular Dystrophy) (Musculoskeletal Disorders) - Drugs in Development, 2021 SUMMARY Laminin-Deficient Congenital Muscular Dy...

April 2021 30 pages

Large Conductance Mechanosensitive Channel (mscL) - Drugs in Development, 2021

 US$ 3,000.00

Large Conductance Mechanosensitive Channel (mscL) - Drugs in Development, 2021 SUMMARY Large Conductance Mechanosensitive Channel (mscL) - Drugs in Development, 2021 provides in depth analysis on Larg...

April 2021 30 pages

Laryngeal Cancer (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Laryngeal Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Laryngeal Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Laryngeal Cancer pipeline landscape. The report pr...

April 2021 75 pages

Lennox-Gastaut Syndrome (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Lennox-Gastaut Syndrome (Central Nervous System) - Drugs in Development, 2021 SUMMARY Lennox-Gastaut Syndrome (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Lennox-G...

April 2021 45 pages

Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) (Oncology) - Drugs in Development, 2021 SUMMARY Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatos...

April 2021 55 pages

Letterer-Siwe Disease (Multifocal and multisystemic (disseminated) Langerhans-cell histiocytosis) (Genetic Disorders) - Drugs in Development, 2021

 US$ 2,000.00

Letterer-Siwe Disease (Multifocal and multisystemic (disseminated) Langerhans-cell histiocytosis) (Genetic Disorders) - Drugs in Development, 2021 SUMMARY Letterer-Siwe Disease (Multifocal and multisy...

April 2021 30 pages

Leukocyte Immunoglobulin Like Receptor Subfamily B Member 2 (CD85 Antigen Like Family Member D or Immunoglobulin Like Transcript 4 or Monocyte/Macrophage Immunoglobulin Like Receptor 10 or CD85d or LILRB2) - Drugs in Development, 2021

 US$ 3,000.00

Leukocyte Immunoglobulin Like Receptor Subfamily B Member 2 (CD85 Antigen Like Family Member D or Immunoglobulin Like Transcript 4 or Monocyte/Macrophage Immunoglobulin Like Receptor 10 or CD85d or LI...

April 2021 30 pages

Leukotriene B4 (LTB4) - Drugs in Development, 2021

 US$ 3,000.00

Leukotriene B4 (LTB4) - Drugs in Development, 2021 SUMMARY Leukotriene B4 (LTB4) - Drugs in Development, 2021 provides in depth analysis on Leukotriene B4 (LTB4) targeted pipeline therapeutics. The re...

April 2021 35 pages

Lewy body Dementia (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Lewy body Dementia (Central Nervous System) - Drugs in Development, 2021 SUMMARY Lewy body Dementia (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Lewy body Dementia...

April 2021 65 pages

Limb-Girdle Muscular Dystrophy (Musculoskeletal Disorders) - Drugs in Development, 2021

 US$ 2,000.00

Limb-Girdle Muscular Dystrophy (Musculoskeletal Disorders) - Drugs in Development, 2021 SUMMARY Limb-Girdle Muscular Dystrophy (Musculoskeletal Disorders) - Drugs in Development, 2021 provides an over...

April 2021 50 pages

Limbal Stem Cell Deficiency (LSCD) (Ophthalmology) - Drugs in Development, 2021

 US$ 2,000.00

Limbal Stem Cell Deficiency (LSCD) (Ophthalmology) - Drugs in Development, 2021 SUMMARY Limbal Stem Cell Deficiency (LSCD) (Ophthalmology) - Drugs in Development, 2021 provides an overview of the Limb...

April 2021 30 pages

Lipase (EC 3.1.1.) - Drugs in Development, 2021

 US$ 3,000.00

Lipase (EC 3.1.1.) - Drugs in Development, 2021 SUMMARY Lipase (EC 3.1.1.) - Drugs in Development, 2021 provides in depth analysis on Lipase (EC 3.1.1.) targeted pipeline therapeutics. The report prov...

April 2021 30 pages

Lipid Disorders (Metabolic Disorders) - Drugs in Development, 2021

 US$ 2,000.00

Lipid Disorders (Metabolic Disorders) - Drugs in Development, 2021 SUMMARY Lipid Disorders (Metabolic Disorders) - Drugs in Development, 2021 provides an overview of the Lipid Disorders pipeline lands...

April 2021 35 pages

Lipodystrophy (Lipoatrophy) (Metabolic Disorders) - Drugs in Development, 2021

 US$ 2,000.00

Lipodystrophy (Lipoatrophy) (Metabolic Disorders) - Drugs in Development, 2021 SUMMARY Lipodystrophy (Lipoatrophy) (Metabolic Disorders) - Drugs in Development, 2021 provides an overview of the Lipody...

April 2021 35 pages

Lipopolysaccharide (Endotoxin) - Drugs in Development, 2021

 US$ 3,000.00

Lipopolysaccharide (Endotoxin) - Drugs in Development, 2021 SUMMARY Lipopolysaccharide (Endotoxin) - Drugs in Development, 2021 provides in depth analysis on Lipopolysaccharide (Endotoxin) targeted pi...

April 2021 45 pages

Liposarcoma (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Liposarcoma (Oncology) - Drugs in Development, 2021 SUMMARY Liposarcoma (Oncology) - Drugs in Development, 2021 provides an overview of the Liposarcoma pipeline landscape. The report provides comprehe...

April 2021 80 pages

Liver Cancer (Oncology) - Drugs in Development, 2021

 US$ 2,500.00

Liver Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Liver Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Liver Cancer pipeline landscape. The report provides compr...

April 2021 325 pages

Liver Fibrosis (Gastrointestinal) - Drugs in Development, 2021

 US$ 2,500.00

Liver Fibrosis (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Liver Fibrosis (Gastrointestinal) - Drugs in Development, 2021 provides an overview of the Liver Fibrosis pipeline landscape. The...

April 2021 210 pages

Liver X Receptor (LXR) - Drugs in Development, 2021

 US$ 3,000.00

Liver X Receptor (LXR) - Drugs in Development, 2021 SUMMARY Liver X Receptor (LXR) - Drugs in Development, 2021 provides in depth analysis on Liver X Receptor (LXR) targeted pipeline therapeutics. The...

April 2021 30 pages

Local Anesthetic Effect (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Local Anesthetic Effect (Central Nervous System) - Drugs in Development, 2021 SUMMARY Local Anesthetic Effect (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Local An...

April 2021 35 pages

Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b (CDw32 or Fc Gamma RII-b or CD32 or FCGR2B) - Drugs in Development, 2021

 US$ 3,000.00

Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b (CDw32 or Fc Gamma RII-b or CD32 or FCGR2B) - Drugs in Development, 2021 SUMMARY Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b (CD...

April 2021 35 pages

Low Density Lipoprotein Receptor Related Protein 6 (LRP6) - Drugs in Development, 2021

 US$ 3,000.00

Low Density Lipoprotein Receptor Related Protein 6 (LRP6) - Drugs in Development, 2021 SUMMARY Low Density Lipoprotein Receptor Related Protein 6 (LRP6) - Drugs in Development, 2021 provides in depth...

April 2021 30 pages

Low-Grade Glioma (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Low-Grade Glioma (Oncology) - Drugs in Development, 2021 SUMMARY Low-Grade Glioma (Oncology) - Drugs in Development, 2021 provides an overview of the Low-Grade Glioma pipeline landscape. The report pr...

April 2021 50 pages

Lung Adenocarcinoma (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Lung Adenocarcinoma (Oncology) - Drugs in Development, 2021 SUMMARY Lung Adenocarcinoma (Oncology) - Drugs in Development, 2021 provides an overview of the Lung Adenocarcinoma pipeline landscape. The...

April 2021 100 pages

Lung Disease (Respiratory) - Drugs in Development, 2021

 US$ 2,000.00

Lung Disease (Respiratory) - Drugs in Development, 2021 SUMMARY Lung Disease (Respiratory) - Drugs in Development, 2021 provides an overview of the Lung Disease pipeline landscape. The report provides...

April 2021 85 pages

Lung Infections (Respiratory) - Drugs in Development, 2021

 US$ 2,000.00

Lung Infections (Respiratory) - Drugs in Development, 2021 SUMMARY Lung Infections (Respiratory) - Drugs in Development, 2021 provides an overview of the Lung Infections pipeline landscape. The report...

April 2021 45 pages

Lung Injury (Respiratory) - Drugs in Development, 2021

 US$ 2,000.00

Lung Injury (Respiratory) - Drugs in Development, 2021 SUMMARY Lung Injury (Respiratory) - Drugs in Development, 2021 provides an overview of the Lung Injury pipeline landscape. The report provides co...

April 2021 50 pages

Lupus Erythematosus (Immunology) - Drugs in Development, 2021

 US$ 2,000.00

Lupus Erythematosus (Immunology) - Drugs in Development, 2021 SUMMARY Lupus Erythematosus (Immunology) - Drugs in Development, 2021 provides an overview of the Lupus Erythematosus pipeline landscape....

April 2021 40 pages

Filters

Clear all

Search

Categories

153
299
490
372
93
184
386
14,910
12,134
222
1,273
225
433
345
3,983
72
1,120

Publishers

2,237
1,678
72
37
1
4,083
2,049
451
220
650
292
33
4
2,631
796
123
12
81
339
120
1,132
5
6
6
23
18
40
259
30
34
6,128
13
12
142
363
8
25
84
660
8
14
8
49
197
7
2,296
266
579
2,792
7
24
44
31
54
92
7
2,538
40
34
11
22
16
38
2
4
97
4
26
50
1
214
11
120
36
21
227
32
50
27
32
42
878
54
326
51
88
92
60
37
2
14
22
2

Regions

102
85
28
27
26
26
17
14
10
9
7
7
7
7
6
5
3
3
2
2
1
1,629
258
224
198
178
117
113
104
78
73
61
53
42
42
39
36
35
33
30
30
29
29
20
20
20
19
18
18
17
15
15
15
14
13
13
13
13
13
12
12
12
12
12
11
11
11
11
11
10
10
10
9
7
6
6
5
201
260
22
21
883
256
141
68
57
34
29
6
6
6
6
5
5
4
3
3
5
5
5
4
3
2
1
1
1
1
2
2
462
29,919

Price

—

Date

—

Pages

—

Offers

44
5
1